Technical FAQ

Shanghai Canbi technology question and answer column provides questions and answers about reference preparations, pharmaceutical intermediates, original research drugs, impurity reference substances, development of original medical samples and blood wave products. Specialized in the solution of all kinds of pharmaceutical chemical products, including but not limited to the production of pharmaceutical products, sales, physical and chemical properties, SDS sources, safety data, EINESC number and use of questions.

Featured Products

• 
  Dicobalt octacarbonyl
  CAS：10210-68-1
  Molecular Formula：Co2(CO)₈
• 
  2,3,4-Trihydroxybenzaldehyde
  CAS：2144-08-3
  Molecular Formula：C₇H₆O₄
• 
  Guanidine hydrochloride
  CAS：50-01-1
  Molecular Formula：CH₅N₃.HCl
• 
  DL-Serinohydrazide monohydrochloride
  CAS：55819-71-1
  Molecular Formula：C₃H₉N₃O₂.ClH
• 
  2,4,6-Tri(2,4-dihydroxyphenyl)-1,3,5-triazine
  CAS：2125-23-7
  Molecular Formula：C₂₁H₁₅N₃O₆
• 
  2,3-Dimethyl-6-amino-2H-indazole
  CAS：444731-72-0
  Molecular Formula：C₉H₁₁N₃
• 
  S-ETHYLISOTHIOUREA HYDROBROMIDE
  CAS：1071-37-0
  Molecular Formula：
• 
  1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)-
  CAS：1360105-53-8
  Molecular Formula：

Latest News

• 1、 Allegro Ophthalmics Announces Positive Results of Vehicle-controlled Ex-U.S. Phase 2 Trial of ALG-1007 for the Treatment of Dry Eye Disease
• 2、 Janssen Licenses "Flexible Antibody" Technology from F-star in New Collab
• 3、 Palleon to Present Preclinical Data on Lead Immuno-Oncology Program, E-602, at SITC Annual Meeting
• 4、 Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818
• 5、 Vifor Pharma and Angion report topline results from phase-III registration trial of ANG-3777 in kidney transplant patients at risk for delayed graft function